Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Effectiveness of a mHealth Intervention for the Treatment of Depression in People With Diabetes or Hypertension in Peru [Phase 3]
Phase 3 trial evaluating a mobile health intervention for treating depression in people with diabetes or hypertension in Peru; study complet…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder [Phase 2]
Phase 2 trial assessing once-daily BTRX-246040 in patients with major depressive disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression [Phase 2]
Phase 2 trial update on Microbial Ecosystem Therapeutic-2 for major depressive disorder and anxiety, focusing on safety, efficacy, and toler…
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study [NA]
A completed proof-of-concept clinical trial evaluating Neuromodulation Enhanced Cognitive Restructuring for anxiety and depression, with res…
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder [NA]
A completed clinical trial evaluating virtual reality behavioral activation for major depressive disorder; results posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Ketamine for Depression Relapse Prevention Following ECT [EARLY_Phase 1]
Early-phase trial investigating ketamine for relapse prevention of depression after electroconvulsive therapy has completed with posted resu…
-
FDA approval · 2021-05-03FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved the original application for sertraline hydrochloride generic by XLCare Pharmaceuticals, enabling a generic version to be marke…
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Healthy Hearts Healthy Minds [NA]
Clinical trial update for the Healthy Hearts Healthy Minds study has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies) [NA]
A completed clinical trial evaluating a program to build community capacity for disability prevention among minority elders with depression …
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Thinking Healthy Program Peer Delivered Plus [NA]
Completed clinical trial assessing Thinking Healthy Program Peer Delivered Plus for depression; results posted in 2021.
-
FDA approval · 2021-04-27FDA Approved: VILAZODONE HYDROCHLORIDE — Original Application (Accord Healthcare Inc.)
FDA approved Vilazodone hydrochloride from Accord Healthcare as an original ANDA, providing a generic option for the antidepressant Vilazodo…
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD) [Phase 4]
Phase 4 trial update evaluating vortioxetine in patients with major depressive disorder coexisting with generalized anxiety disorder has bee…
-
FDA approval · 2021-04-19FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., updating the generic's labeling under the AN…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Nitrous Oxide for Major Depressive Disorder [Phase 2]
Phase 2 clinical trial update for nitrous oxide targeting major depressive disorder has completed.
-
FDA approval · 2021-04-07FDA Approved: VILAZODONE HYDROCHLORIDE — Original Application (Exelan Pharmaceuticals Inc.)
The FDA approved Exelan Pharmaceuticals’ original Abbreviated New Drug Application for vilazodone hydrochloride, establishing a generic vers…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Telehealth Cognitive Behavioral Therapy for Depression in Parkinson's Disease (PD) [NA]
A completed clinical trial evaluating telehealth-based cognitive behavioral therapy for depression in Parkinson's disease with results poste…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Study of a Transdiagnostic, Emotion-focused Group Intervention for Young Adults With Substance Use Disorders [NA]
A completed clinical trial assessing a transdiagnostic, emotion-focused group intervention for young adults with substance use disorders, wi…
-
CLINICAL_TRIALS research · 2021-03-30Clinical Trial Update: Supported Employment in Patient Aligned Care Teams [NA]
Clinical trial update on supported employment within patient-aligned care teams, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy [Phase 3]
Phase 3 trial evaluating vortioxetine for depression associated with radiation injuries in patients with head and neck cancer undergoing rad…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder [Phase 3]
Phase 3 trial assessing efficacy and safety of AXS-05 in treatment-resistant major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Neural Changes Associated With a Mindfulness-based Intervention for Young Adults With Childhood Maltreatment [NA]
Completed clinical trial evaluating neural changes associated with a mindfulness-based intervention in young adults with a history of childh…
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Wake Therapy in the Treatment of Depression [NA]
Clinical trial update for wake therapy in depression completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD [Phase 2]
Phase 2 trial update for REL-1017 in major depressive disorder shows safety, tolerability, pharmacokinetics, and symptom response with 7-day…
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Cognitive Behavioural Therapy Software for the Treatment of Depression in People With Multiple Sclerosis [NA]
A completed clinical trial evaluating cognitive behavioural therapy software for treating depression in people with multiple sclerosis; resu…
-
FDA approval · 2021-03-16FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Ingenus Pharmaceuticals, LLC)
FDA approved a supplemental application for desipramine hydrochloride submitted by Ingenus Pharmaceuticals, LLC.